| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 10963100 | Vaccine | 2016 | 7 Pages | 
Abstract
												Hantavax⢠showed a booster effect and immunogenicity lasting two years with a three-dose schedule. The neutralizing antibody response was quite poor with two primary doses, so an early booster vaccination at 2-6 months might be warranted to provide timely protection to high-risk subjects.
											Keywords
												
											Related Topics
												
													Life Sciences
													Immunology and Microbiology
													Immunology
												
											Authors
												Joon Young Song, Heung Jeong Woo, Hee Jin Cheong, Ji Yun Noh, Luck Ju Baek, Woo Joo Kim, 
											